Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7086817 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL29894248 | 0.98 | ALDH1A1 (0.54) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL9880954 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL19066838 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL1289280 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL19066837 | 0.98 | ALDH1A1 (0.59) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL1289353 | 0.96 | TSHR (0.56) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| Ethylene SCHEMBL11903760 | 0.94 | ALDH1A1 (0.54) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL1289261 | 0.94 | ALDH1A1 (0.54) | ALDH1A1TSHRFFAR4FFAR1GPR84 | |
| SCHEMBL1687579 | 0.94 | ALDH1A1 (0.54) | ALDH1A1TSHRFFAR4FFAR1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2647394-B1 | Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2018-08-01 | — | — | EP | claimed |
| EP-3730559-B1 | ACTIVE RAY-CURABLE INKJET INK SET AND INKJET RECORDING METHOD | KONICA MINOLTA INC (JP) | 2022-11-02 | — | — | EP | disclosed |
| EP-3594004-B1 | INK-JET RECORDING METHOD AND ACTINIC RAY CURABLE INK-JET INK SET | KONICA MINOLTA INC (JP) | 2021-09-15 | — | — | EP | disclosed |
| EP-3730559-A1 | ACTIVE RAY-CURABLE INKJET INK SET AND INKJET RECORDING METHOD | KONICA MINOLTA, INC. (JP) | 2020-10-28 | — | — | EP | disclosed |
| EP-2647394-B1 | Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct | ABBOTT CARDIOVASCULAR SYSTEMS INC (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2842761-B1 | IMAGE-FORMING METHOD | KONICA MINOLTA INC (JP) | 2018-05-23 | — | — | EP | disclosed |
| EP-2692804-B1 | ACTINIC RAY CURABLE INKJET INK AND IMAGE RECORDING METHOD USING SAME | KONICA MINOLTA INC (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9340693-B2 | Actinic ray curable inkjet ink and image recording method using same | Konica Minolta, Inc. (JP) | 2016-05-17 | — | — | US | disclosed |
| US-9174461-B2 | Image-forming method | Konica Minolta, Inc. (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20150070451-A1 | IMAGE-FORMING METHOD | Konica Minolta, Inc. (JP) | 2015-03-12 | — | — | US | disclosed |
| US-20130134623-A1 | FABRICATING AN IMPLANTABLE MEDICAL DEVICE FROM AN AMORPHOUS OR VERY LOW CRYSTALLINITY POLYMER CONSTRUCT | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-05-30 | — | — | US | disclosed |
| EP-2429601-B1 | FABRICATING AN IMPLANTABLE MEDICAL DEVICE FROM AN AMORPHOUS OR VERY LOW CRYSTALLINITY POLYMER CONSTRUCT | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2013-03-20 | — | — | EP | disclosed |
| US-8394317-B2 | Method of improving fracture toughness of implantable medical devices through annealing | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-03-12 | — | — | US | disclosed |
| US-8372332-B2 | Fabricating an implantable medical device from an amorphous or very low crystallinity polymer construct | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2013-02-12 | — | — | US | disclosed |
| US-8337739-B2 | Improving fracture toughness of medical devices with a stereocomplex nucleating agent | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-12-25 | — | — | US | disclosed |
| EP-2429601-A2 | FABRICATING AN IMPLANTABLE MEDICAL DEVICE FROM AN AMORPHOUS OR VERY LOW CRYSTALLINITY POLYMER CONSTRUCT | Abbott Cardiovascular Systems Inc. (US) | 2012-03-21 | — | — | EP | disclosed |
| WO-2011002554-A2 | FABRICATING AN IMPLANTABLE MEDICAL DEVICE FROM AN AMORPHOUS OR VERY LOW CRYSTALLINITY POLYMER CONSTRUCT | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20100252965-A1 | Fabricating An Implantable Medical Device From An Amorphous Or Very Low Crystallinity Polymer Construct | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2010-10-07 | — | — | US | disclosed |
| US-20100038822-A1 | Fracture Toughness Of Medical Devices With A Stereocomplex Nucleating Agent | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2010-02-18 | — | — | US | disclosed |
| US-20100036478-A1 | Method Of Improving Fracture Toughness Of Implantable Medical Devices Through Annealing | ABBOTT CARDIOVASCULAR SYSTEMS INC | 2010-02-11 | — | — | US | disclosed |